← Back to Search

Other

Normal Medication Positive Control for Type 2 Diabetes

N/A

Waitlist Available

Led By Hugh D Tildesley, MD

Research Sponsored by Endocrine Research Society

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will test whether an online system that monitors blood sugar levels and gives feedback to patients can help manage type 2 diabetes.

Eligible Conditions

Type 2 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interventional procedure

Secondary outcome measures

A secondary endpoint includes adverse events such as unplanned hospitalizations for any cause that last more than 24 hours

HbA1c levels remain at 8% or higher

The secondary endpoint include severe hypoglycemia defined as requiring external aid (hospital or other).

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Normal Medication Positive ControlExperimental Treatment1 Intervention

The subjects will be prescribed a new medication as appropriate for normal therapy. This group will receive no biweekly feedback nor require to report online, but will see the endocrinologist every 3 months up to 6 months.

Group II: Internet-Based Glucose Monitoring SystemActive Control1 Intervention

The subjects enrolled in the Internet Therapeutic Intervention arm receive standard care by testing their blood glucose at least 3 times daily and visit the endocrinologist every 3 months; however, they are also asked to upload their blood glucose readings online every 2 weeks for the health practitioner to view and provide feedback limited to non-medicine related comments and suggestions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Normal Medication Positive Control

2014

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Endocrine Research SocietyLead Sponsor

11 Previous Clinical Trials

434 Total Patients Enrolled

Hugh D Tildesley, MDPrincipal InvestigatorProvidence Health Care, University of British Columbia

5 Previous Clinical Trials

300 Total Patients Enrolled

Media Library

Internet-Based Glucose Monitoring System (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02185755 — N/A

Type 2 Diabetes Research Study Groups: Internet-Based Glucose Monitoring System, Normal Medication Positive Control

Type 2 Diabetes Clinical Trial 2023: Internet-Based Glucose Monitoring System Highlights & Side Effects. Trial Name: NCT02185755 — N/A

Internet-Based Glucose Monitoring System (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02185755 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open vacancies for this experimental protocol?

"As detailed on clinicaltrials.gov, this study is not presently welcoming any further participants. It was first posted in August 1st 2014 and the last edit occurred 3 years later in 2017. Although it is no longer enrolling patients, there are 1441 other medical trials actively seeking volunteers at this time."

Answered by AI

Does this research endeavor include participants over the age of twenty?

"To be eligible for this medical trial, individuals must fall between the ages of 18 and 80. For those younger than 18 there are 192 studies available, while 1104 trials exist for seniors above 65 years old."

Answered by AI